The UAE research community's interest in tesamorelin has outpaced the region's supply chain infrastructure. Most peptides UAE suppliers operating here ship from overseas, provide no COA, apply no HPLC standard, and use standard courier packaging that breaks the cold chain somewhere between the warehouse and the door. The result is a vial that looks correct, reconstitutes normally, and produces data that cannot be trusted — or compared to anything published. This post is for investigators who already know the mechanism and are asking a harder question: where in the UAE can I actually buy tesamorelin that meets the purity and documentation standard used in the trials? REVIVE LAB UAE was built to answer that question operationally, not just rhetorically.
Tesamorelin is a 44-amino-acid synthetic analog of human growth-hormone-releasing hormone (GHRH 1-44), modified at the N-terminus with a trans-3-hexenoyl group that confers resistance to DPP-IV cleavage and extends the effective half-life. At that molecular weight and structural complexity, synthesis purity is not a binary — it is a gradient. A batch testing at 85% purity by HPLC contains 15% of content that is a mixture of truncated fragments, oxidized byproducts, and dimeric species. Those impurities do not simply do nothing: they compete for GHRH receptor binding, potentially elicit off-target immune responses in research models, and — most critically — they dilute the active fraction, making dose-response data unreplicable.
The pivotal efficacy data most UAE investigators reference is Falutz et al. 2007 — a 412-subject randomised, placebo-controlled NEJM trial that showed tesamorelin 2mg/day SC reduced visceral adipose tissue (VAT) by 15-18% and raised IGF-1 by approximately 50% relative to placebo over 26 weeks in HIV-associated lipodystrophy. That trial used investigational tesamorelin manufactured to pharmaceutical-grade purity. If a research protocol uses a vial at 85% purity and expects comparable metabolic endpoints, the protocol is already broken before the first data point is recorded.
The supply chain standard, therefore, is not an optional add-on — it is a prerequisite for any data worth generating.
The phrase "research grade" is used loosely in the peptides UAE market. Used correctly, it refers to a specific set of analytical tests performed on each lot before release. REVIVE LAB UAE applies the following minimum release standards to every tesamorelin batch:
When you request a COA for a tesamorelin UAE order from REVIVE LAB UAE, the document will include: lot number, synthesis date, HPLC purity percentage with reference to the chromatogram, ESI-MS result with observed vs. expected mass, endotoxin result in EU/mg, and moisture content. The lot number is the critical traceability anchor — it links your vial to a specific synthesis run, making it possible to reorder from the identical batch or to flag any anomaly to a specific production event. Suppliers who provide a generic COA without a lot number are providing a document that is analytically meaningless.
Understanding the published data is inseparable from understanding the supply chain that produced it. The four landmark tesamorelin studies used investigational material manufactured under tightly controlled conditions and stored at 2-8°C from synthesis to administration — a standard most peptides UAE suppliers do not meet.
| Study | Journal | Design | Key Finding |
|---|---|---|---|
| Falutz et al. 2007 | N Engl J Med | 412-subject RCT, 26 weeks, HIV lipodystrophy | VAT reduced 15-18%; IGF-1 increased ~50% vs placebo at 2mg/day |
| Falutz et al. 2010 | J Clin Endocrinol Metab | 26-week blinded extension of the 2007 cohort | VAT reduction sustained; benefit reversed on discontinuation, confirming on-target mechanism |
| Stanley et al. 2014 | JAMA | 61-subject RCT, HIV-associated NAFLD | Liver fat reduced 32% relative to placebo over 12 months at 2mg/day |
| Stanley et al. 2019 | Lancet HIV | 12-month NAFLD extension, multi-centre | Liver fat reduction confirmed at 12 months; hepatic insulin sensitivity improved |
Two operational details run through all four protocols. First, dosing was 1mg/day or 2mg/day subcutaneous — the research-context range that research investigators reference when designing tesamorelin protocols. Second, the investigational product was stored at 2-8°C continuously and reconstituted within strict time windows. Stanley's group at Massachusetts General Hospital effectively validated the supply chain as part of the protocol, even if the paper doesn't call it that. Investigators in the UAE attempting to reproduce metabolic or hepatic endpoints from this literature need tesamorelin vials that meet the same purity and handling standards — which is precisely the specification REVIVE LAB UAE sources and dispatches.
REVIVE LAB UAE stocks tesamorelin in two vial formats. Both meet the same HPLC ≥99% purity standard and ship with the same lot-COA documentation. The choice between them is purely a protocol design question — specifically, how your investigators are calculating per-vial utilisation and reconstitution schedule.
| Format | Reconstitution Volume | Concentration | Doses per Vial (1mg/day) | Doses per Vial (2mg/day) |
|---|---|---|---|---|
| Tesamorelin 5mg | 2.5mL BAC water | 2mg/mL | 5 doses | 2.5 doses |
| Tesamorelin 5mg | 1mL BAC water | 5mg/mL | 5 doses | 2.5 doses |
| Tesamorelin 10mg | 2mL BAC water | 5mg/mL | 10 doses | 5 doses |
| Tesamorelin 10mg | 5mL BAC water | 2mg/mL | 10 doses | 5 doses |
For multi-week research runs at 2mg/day (the Falutz protocol dose), the 10mg vial format reduces the number of reconstitution events, which in turn reduces the number of opportunities for contamination and stability clock resets. For shorter pilot protocols at 1mg/day research-context dosing, 5mg vials provide cleaner lot-to-lot traceability across the study window. Both formats are available for same-day order in the UAE from REVIVE LAB UAE, with cold-chain dispatch to your emirate.
The supply chain is the part most peptides UAE suppliers gloss over in marketing copy and fail at operationally. REVIVE LAB UAE built its fulfillment architecture around a single constraint: tesamorelin must arrive at the researcher's door at 2-8°C, not "approximately cold." Here is what that means in practice.
Vials are stored in pharmaceutical cold storage at 2-8°C from receipt through dispatch. REVIVE LAB UAE does not hold ambient-temperature warehouse stock and pack it with gel packs at the last minute. Packing occurs inside a temperature-controlled room. Every shipment uses validated insulated packaging with phase-change material validated to hold 2-8°C for a minimum of 24 hours in 40°C ambient — which covers any UAE summer transit scenario.
Every order is linked to a specific lot number in REVIVE LAB UAE's inventory system. If a researcher orders tesamorelin in stock UAE today and reorders in three weeks, they can specify the same lot number and receive material from an identical synthesis run — critical for multi-week protocols where inter-lot variability would confound data. This level of traceability is standard in pharmaceutical procurement and absent in most peptides Dubai suppliers operating in this market.
REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched tesamorelin across all 7 emirates. Researchers in Dubai who need tesamorelin same day delivery receive priority dispatch; every other emirate falls inside the 24-hour cold-chain window.
| Location | Delivery Window | Cash on Delivery | Cold-Chain Packaging |
|---|---|---|---|
| Dubai (Marina, JBR, Business Bay, DIFC, Downtown, Palm, Jumeirah, JVC) | Same-day, 4-8 hours | Yes | Yes — validated insulated pack |
| Abu Dhabi (Corniche, Yas, Saadiyat, Khalidiyah) | Next-day, 18-24 hours | Yes | Yes |
| Sharjah | Same-day / next-day, 8-18 hours | Yes | Yes |
| Ajman | Next-day, 18-24 hours | Yes | Yes |
| Ras Al Khaimah | Next-day, 18-24 hours | Yes | Yes |
| Fujairah | Next-day, 24 hours | Yes | Yes |
| Umm Al Quwain | Next-day, 18-24 hours | Yes | Yes |
For investigators based outside Dubai who need to confirm tesamorelin in stock UAE before committing a protocol timeline to delivery windows, REVIVE LAB UAE's current stock position on 5mg and 10mg vials can be confirmed at order. Tesamorelin cash on delivery Dubai is available at no surcharge — no prepayment required for same-day Dubai orders.
Even when sourcing from a documented supplier, investigators should run a brief incoming QC check on every vial before committing it to a protocol. The following three-step visual and documentation protocol takes under five minutes and confirms the vial is suitable for use.
This three-step check adds approximately five minutes of upfront work and eliminates the most common sources of within-protocol variance attributable to material quality rather than experimental design.
REVIVE LAB UAE requires a minimum 99% purity by reverse-phase HPLC for every tesamorelin batch before release. Each lot ships with a full Certificate of Analysis confirming identity by mass spectrometry, HPLC purity percentage, endotoxin level (<1 EU/mg by LAL test), moisture content and sterility. Investigators can request the COA PDF for any lot at the time of placing their order. The lot number on the vial label links directly to the COA on file — there is no generic or undated certificate in circulation.
Yes. REVIVE LAB UAE currently stocks tesamorelin in both 5mg and 10mg lyophilized vial formats and offers tesamorelin same day Dubai delivery for orders placed before the daily cut-off. Tesamorelin Dubai 24h delivery covers all seven emirates — Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain receive next-day cold-chain dispatch. Cash on delivery is available across the UAE and requires no prepayment. For researchers outside Dubai, confirming tesamorelin in stock UAE before ordering takes one message to REVIVE LAB UAE.
The published protocols by Falutz et al. (NEJM 2007, extension 2010) and Stanley et al. (JAMA 2014, Lancet HIV 2019) used investigational tesamorelin manufactured to pharmaceutical-grade purity and stored at 2-8°C throughout the trial period. Investigators designing research protocols that reference these studies — whether for VAT endpoints (Falutz cohort: -15-18% at 2mg/day) or hepatic fat endpoints (Stanley cohort: -32% at 12 months) — need a tesamorelin UAE supplier using the same purity benchmarks. HPLC ≥99%, lot-COA, sterility-confirmed, cold-chain dispatched. Sourcing below that standard makes the comparison to published literature analytically invalid.